Enbrel
| Name | Enbrel |
|---|---|
| Active Substance | etanercept |
| Prescription | na recept |
| Type of prescription | ograničeni recept (prašak i otapalo za otopinu za injekciju, prašak za otopinu za injekciju, otopina za injekciju u napunjenoj štrcaljki, otopina za injekciju u napunjenoj brizgalici, prašak i otapalo za otopinu za injekciju za pedijatrijsku primjenu) |
| Distribution | u ljekarni |
| ATC Code | L04AB01 |
| Medicinal product marketed in the Croatia | Da |
| Educational materials for healthcare professionals |
Vodič za zdravstvene djelatnike (flipchart), verzija 3 |
| Educational materials for patients / caregivers |
Vodič za primjenu lijeka namijenjen bolesnicima (brošura), verzija 3 |
Note
The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/enbrel
The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm
